Molecular Immunology Unit, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium.
Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium.
Mod Pathol. 2017 Sep;30(9):1204-1212. doi: 10.1038/modpathol.2017.43. Epub 2017 Jun 16.
The presence of tumor-infiltrating lymphocytes (TIL), reflecting host immune activity, is frequently correlated with better clinical outcomes, particularly in HER2-positive and triple-negative breast cancer. Recent findings suggest that organization of immune infiltrates in tertiary lymphoid structures also has a beneficial effect on survival. This study investigated inter- and intra-observer variation in TIL assessment using conventional hematoxylin-eosin versus immunohistochemical staining to identify immune cells. Global, intratumoral, and stromal TIL, as well as tertiary lymphoid structures were scored independently by experienced pathologists on full-face tumor sections (n=124). The fidelity of scoring infiltrates in core biopsies compared to surgical specimens, and pathological assessment compared to quantitative digital analysis was also evaluated. The inter-observer concordance correlation coefficient was 0.80 for global, 0.72 for intratumoral, and 0.71 for stromal TIL, while the intra-observer concordance correlation coefficient was 0.90 for global, 0.77 for intratumoral, and 0.89 for stromal TIL using immunohistochemical stains. Correlations were lower with hematoxylin-eosin stains, particularly for intratumoral TIL, while global scores had the highest concordance correlation coefficients. Our study concluded that tertiary lymphoid structures are accurately and consistently scored using immunohistochemical but not hematoxylin-eosin stains. A strong association was observed between TIL in core biopsies and surgical samples (R=0.74) but this did not extend to tertiary lymphoid structures (R=0.26). TIL scored by pathologists and digital analysis were correlated but our analysis reveals a constant bias between these methods. These data challenge current criteria for TIL and tertiary lymphoid structure assessment in breast cancer and recommend that how pathologists evaluate immune infiltrates be reexamined for future studies.
肿瘤浸润淋巴细胞(TIL)的存在反映了宿主的免疫活性,常与更好的临床结局相关,尤其是在 HER2 阳性和三阴性乳腺癌中。最近的研究结果表明,三级淋巴结构中免疫浸润的组织也对生存有有益的影响。本研究使用常规苏木精-伊红染色和免疫组织化学染色来识别免疫细胞,评估 TIL 评估的观察者内和观察者间差异。经验丰富的病理学家分别对全脸肿瘤切片(n=124)进行了全局、肿瘤内和基质 TIL 以及三级淋巴结构的评分。还评估了核心活检与手术标本的评分浸润的准确性,以及病理评估与定量数字分析的一致性。全局、肿瘤内和基质 TIL 的观察者间一致性相关系数分别为 0.80、0.72 和 0.71,而使用免疫组织化学染色时,全局、肿瘤内和基质 TIL 的观察者内一致性相关系数分别为 0.90、0.77 和 0.89。使用苏木精-伊红染色时,相关性较低,特别是对于肿瘤内 TIL,而全局评分具有最高的一致性相关系数。我们的研究得出结论,使用免疫组织化学而不是苏木精-伊红染色可以准确一致地对三级淋巴结构进行评分。核心活检和手术样本中的 TIL 之间观察到强烈的相关性(R=0.74),但这种相关性不适用于三级淋巴结构(R=0.26)。病理学家和数字分析评分的 TIL 相关,但我们的分析显示这两种方法之间存在恒定的偏差。这些数据对乳腺癌中 TIL 和三级淋巴结构评估的现行标准提出了挑战,并建议重新检查病理学家评估免疫浸润的方法,以便用于未来的研究。